juin 18, 2024 Policy Analysis Midyear 2024 State Policy Trends: Many US States Attack Reproductive Health Care, as Other States Fight Back
juin 13, 2024 News Release Latest Data Confirm People Are Traveling Farther Distances to Access Abortion Care Post-Dobbs
juin 13, 2024 Statement Destiny Lopez, Acting Co-CEO of the Guttmacher Institute, on the US Supreme Court's Decision in FDA v. AHM
juin 12, 2024 Statement Testimony of Isaac Maddow-Zimet, Guttmacher Data Scientist, before the U.S. Senate Subcommittee on Federal Courts, Oversight, Agency Action, and Federal Rights
juin 10, 2024 News Release Data for Democracy: The Essential Role of Guttmacher Evidence in a Post-Roe World
juin 4, 2024 Statement Testimony of Destiny Lopez Guttmacher Acting Co-CEO before the U.S. Senate Committee on Health, Education, Labor, and Pensions
juin 1, 2024 Research Article Motivations for using misoprostol for abortion outside the formal healthcare system in Colombia: a qualitative study of women seeking postabortion care in Bogotá and the Coffee Axis Juliette Ortiz, Nakeisha Blades and Elena Prada Reproductive Health
mai 31, 2024 Policy Analysis Clear and Growing Evidence That Dobbs Is Harming Reproductive Health and Freedom
mai 20, 2024 News Release Guttmacher Joins US and Latin American Abortion Activists to Mobilize Against Reproductive Oppression
